Semler Scientific’s Q1 2025: Bitcoin Strategy and Financial Challenges

Semler Scientific ( (SMLR) ) has released its Q1 earnings. Here is a breakdown of the information Semler Scientific presented to its investors.

Semler Scientific, Inc. is a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is a leading corporate holder of bitcoin, while also developing healthcare technology products to assist in evaluating and treating chronic diseases.

In its first quarter of 2025 financial results, Semler Scientific reported a significant focus on its bitcoin holdings, achieving a BTC Yield of 21.9% in Q1 and 22.2% year-to-date. The company has accumulated 3,808 bitcoins, valued at $387.9 million, as part of its strategic treasury reserve. Additionally, Semler Scientific launched a new dashboard to provide updated information on its bitcoin holdings and other key metrics.

Financially, the company faced a challenging quarter with revenues of $8.8 million, a 44% decrease year-over-year, and a net loss of $64.7 million. This was largely due to a $41.8 million unrealized loss from the change in fair value of its bitcoin holdings and a $29.8 million contingent liability related to a potential settlement with the DOJ. Despite these setbacks, Semler Scientific continues to leverage its healthcare business, particularly its cardiovascular product line, to drive future growth.

Strategically, Semler Scientific has been active in financing, issuing $100 million in convertible notes and entering a new equity offering agreement to raise up to $500 million. The company also resumed settlement discussions with the DOJ, reaching an agreement in principle for a $29.75 million settlement.

Looking forward, Semler Scientific remains committed to its bitcoin treasury strategy while expecting growth from its healthcare products. The management is optimistic about cash generation from its FDA-cleared products, which will support its ongoing strategic initiatives.